BDBM541886 US11267824, Example 96::US11267824, Example 96a

SMILES CCc1sc2cncn2c1C(O)C1CCCCC1

InChI Key InChIKey=KVZWTSMKWDGVKG-UHFFFAOYSA-N

Data  4 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 541886   

TargetIndoleamine 2,3-dioxygenase 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM541886(US11267824, Example 96a | US11267824, Example 96)
Affinity DataIC50: 5.32nMAssay Description:IDO1: Recombinant full-length human IDO1 with a N-terminal hexahistidine tag expressed in E. coli and purified to homogeneity is incubated at a final...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetIndoleamine 2,3-dioxygenase 1(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM541886(US11267824, Example 96a | US11267824, Example 96)
Affinity DataIC50: 10.5nMAssay Description:IDO1: Recombinant full-length human IDO1 with a N-terminal hexahistidine tag expressed in E. coli and purified to homogeneity is incubated at a final...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM541886(US11267824, Example 96a | US11267824, Example 96)
Affinity DataIC50: 20nMAssay Description:TDO2: Recombinant human TDO comprising amino acids 19-407 with a N-terminal hexahistidine tag expressed in E. coli and purified to homogeneity is inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent

TargetTryptophan 2,3-dioxygenase(Human)
Idorsia Pharmaceuticals

US Patent
LigandPNGBDBM541886(US11267824, Example 96a | US11267824, Example 96)
Affinity DataIC50: 39.9nMAssay Description:TDO2: Recombinant human TDO comprising amino acids 19-407 with a N-terminal hexahistidine tag expressed in E. coli and purified to homogeneity is inc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2022
Entry Details
US Patent